性能参数

产品名称

Asperosaponin VI

规格

5mg 10mg 20mg

货号

GOY-Y0622

 含量

>98.00%

CAS

39524-08-8

别名

N/A

化学名

N/A

分子式

C47H76O18

分子量

分子 929.1

溶解度

DMSO: 100 mg/mL (107.63 mM)

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Asperosaponin VI, A saponin component from Dipsacus asper wall, induces osteoblast differentiation through BMP‐2/p38 and ERK1/2 pathway[1]. Asperosaponin Ⅵ inhibits apoptosis in hypoxia-induced cardiomyocyte by increasing the Bcl-2/Bax ratio and decreasing active caspase-3 expression, as well as enhancing of p-Akt and p-CREB[2].

[1]. Niu Y, et al. Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytother Res. 2011 Nov;25(11):1700-6. [2]. Li C, et al. Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways. Eur J Pharmacol. 2010 Dec 15;649(1-3):100-7.

3-keto Fusidic Acid CS-01Y63512 1mg >95.00% 4680-37-9

3-Methoxybenzoic acid (3-Anisic acid) CS-01Y63513 5g >98.00% 586-38-9

3-Methoxytyramine (3-O-methyl Dopamine) CS-01Y63514 100mg 250mg 500mg >98.00% 554-52-9

3-Methyl-2-buten-1-ol CS-01Y63515 100mg >98.?

9,10-双苯乙炔基蒽9,10-Bis(phenylethynyl)anthracene,≥97...10075-85-11G

氧杂蒽Xanthene,≥99.0%92-83-15G

9-甲基蒽9-Methylanthracene ,≥99.0%779-02-21G

9,10-二苯基蒽9,10-Diphenylanthracene1499-10-11G

9,10-二甲基蒽9,10-Dimethylanthracene,≥99.0%781-43-11G

7,12-二甲基苯并[a]蒽7,12-Dimethylbenz[a]anthracene,≥98.0%57-97-6100MG